Training the resident in percutaneous nephrolithotomy

Autor: Ather, M. Hammad, Ng, Chi-Fai, Pourmand, Gholamraza, Osther, Palle J.

Publikováno v: In Arab Journal of Urology March 2014 12(1):49-53

Interim Results from the IMPACT Study:Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Autor: Page, Elizabeth C, Bancroft, Elizabeth K, Brook, Mark N, Assel, Melissa, Hassan Al Battat, Mona, Thomas, Sarah, Taylor, Natalie, Chamberlain, Anthony, Pope, Jennifer, Raghallaigh, Holly Ni, Evans, D Gareth, Rothwell, Jeanette, Maehle, Lovise, Grindedal, Eli Marie, James, Paul, Mascarenhas, Lyon, McKinley, Joanne, Side, Lucy, Thomas, Tessy, van Asperen, Christi, Vasen, Hans, Kiemeney, Lambertus A, Ringelberg, Janneke, Jensen, Thomas Dyrsø, Osther, Palle J S, Helfand, Brian T, Genova, Elena, Oldenburg, Rogier A, Cybulski, Cezary, Wokolorczyk, Dominika, Ong, Kai-Ren, Huber, Camilla, Lam, Jimmy, Taylor, Louise, Salinas, Monica, Feliubadaló, Lidia, Oosterwijk, Jan C, van Zelst-Stams, Wendy, Cook, Jackie, Rosario, Derek J, Domchek, Susan, Powers, Jacquelyn, Buys, Saundra, O'Toole, Karen, Ausems, Margreet G E M, Schmutzler, Rita K, Rhiem, Kerstin, Izatt, Louise, Tripathi, Vishakha, Cardoso, Marta

Publikováno v: Page, E C, Bancroft, E K, Brook, M N, Assel, M, Hassan Al Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, H N, Evans, D G, Rothwell, J, Maehle, L, Grindedal, E M, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, van Asperen, C, Vasen, H, Kiemeney, L A, Ringelberg, J, Jensen, T D, Osther, P J S, Helfand, B T, Genova, E, Oldenburg, R A, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, J C, van Zelst-Stams, W, Cook, J, Rosario, D J, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, M G E M, Schmutzler, R K, Rhiem, K, Izatt, L, Johannsson, O, Rønlund, K & IMPACT Collaborators 2019, ' Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers ', European Urology, vol. 76, no. 6, pp. 831-842 . https://doi.org/10.1016/j.eururo.2019.08.019
European urology, 76(6), 831-842. Elsevier
European Urology, 76(6), 831-842. ELSEVIER SCIENCE BV

BACKGROUND: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations.OBJECTIVE: To rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2bd3ea3f38f0b8f7ee7165d48f8d61c7
https://findresearcher.sdu.dk:8443/ws/files/156391067/Interim_Results_from_the_IMPACT_Study.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Autor: Mikropoulos, Christos, Selkirk, Christina G. Hutten, Saya, Sibel, Bancroft, Elizabeth, Vertosick, Emily, Dadaev, Tokhir, Brendler, Charles, Page, Elizabeth, Dias, Alexander, Evans, D. Gareth, Rothwell, Jeanette, Maehle, Lovise, Axcrona, Karol, Richardson, Kate, Eccles, Diana, Jensen, Thomas, Osther, Palle J., van Asperen, Christi J., Vasen, Hans, Kiemeney, Lambertus A., Ringelberg, Janneke, Cybulski, Cezary, Wokolorczyk, Dominika, Hart, Rachel, Glover, Wayne, Lam, Jimmy, Taylor, Louise, Salinas, Monica, Feliubadalo, Lidia, Oldenburg, Rogier, Cremers, Ruben, Verhaegh, Gerald, van Zelst-Stams, Wendy A., Oosterwijk, Jan C., Cook, Jackie, Rosario, Derek J., Buys, Saundra S., Conner, Tom, Domchek, Susan, Powers, Jacquelyn, Ausems, Margreet G. E. M., Teixeira, Manuel R., Maia, Sofia, Izatt, Louise, Schmutzler, Rita, Rhiem, Kerstin, Foulkes, William D., Boshari, Talia, Davidson, Rosemarie, Ruijs, Marielle, van den Enden, Apollonia, Eeles, Rosalind A.

Publikováno v: British Journal of Cancer, 118(2), 266-276. Nature Publishing Group

Background: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::aff716905653caa6176fc561bf438653
https://cris.maastrichtuniversity.nl/en/publications/e645d3e8-77d3-403e-bc1f-a291c673e2ab